You are currently viewing a new version of our website. To view the old version click .

Pharmaceutics, Volume 12, Issue 10

October 2020 - 96 articles

Cover Story: The concept of nanoemulsion design with biosurfactant was presented, and its efficacy was shown. The encapsulation of active molecules (Vit C and E) in the aggregates system increases their bioavailability and biodistribution. It facilitates controlled release, which is particularly important in the case of skin preparations. The optimal selection of surfactants during the designing of nanoemulsions is of particular importance. Surfactin, which is safe and environmentally friendly, was used to stabilize the interface, which is the essential component of a dispersion system responsible for the unique properties. Developed nanosystems are suitable for encapsulating and delivering lipophilic bioactive components and penetrating the epidermis’ deeper layers. View this paper
  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (96)

  • Article
  • Open Access
6 Citations
2,689 Views
16 Pages

A new organic salt of metformin, an antidiabetic drug, and N,N′-(1,4-phenylene)dioxalamic acid, was mechanochemically synthesized, purified by crystallization from solution and characterized by single X-ray crystallography. The structure reveal...

  • Review
  • Open Access
42 Citations
7,793 Views
42 Pages

Injectables and Depots to Prolong Drug Action of Proteins and Peptides

  • Nkiruka Ibeanu,
  • Raphael Egbu,
  • Lesley Onyekuru,
  • Hoda Javaheri,
  • Peng Tee Khaw,
  • Gareth R. Williams,
  • Steve Brocchini and
  • Sahar Awwad

Proteins and peptides have emerged in recent years to treat a wide range of multifaceted diseases such as cancer, diabetes and inflammation. The emergence of polypeptides has yielded advancements in the fields of biopharmaceutical production and form...

  • Article
  • Open Access
36 Citations
6,420 Views
15 Pages

Physicochemical, Pharmacokinetic, and Toxicity Evaluation of Soluplus® Polymeric Micelles Encapsulating Fenbendazole

  • Ik Sup Jin,
  • Min Jeong Jo,
  • Chun-Woong Park,
  • Youn Bok Chung,
  • Jin-Seok Kim and
  • Dae Hwan Shin

Fenbendazole (FEN), a broad-spectrum benzimidazole anthelmintic, suppresses cancer cell growth through various mechanisms but has low solubility and achieves low blood concentrations, which leads to low bioavailability. Solubilizing agents are requir...

  • Article
  • Open Access
17 Citations
3,633 Views
18 Pages

Oral delivery of therapeutic peptides is hampered by their large molecular size and labile nature, thus limiting their permeation across the intestinal epithelium. Promising approaches to overcome the latter include co-administration with carrier pep...

  • Article
  • Open Access
18 Citations
3,826 Views
11 Pages

Engineered Human Nanoferritin Bearing the Drug Genz-644282 for Cancer Therapy

  • Elisabetta Falvo,
  • Alessandro Arcovito,
  • Giamaica Conti,
  • Giuseppe Cipolla,
  • Martina Pitea,
  • Veronica Morea,
  • Verena Damiani,
  • Gianluca Sala,
  • Giulio Fracasso and
  • Pierpaolo Ceci

Gastrointestinal tumors, including pancreatic and colorectal cancers, represent one of the greatest public health issues worldwide, leading to a million global deaths. Recent research demonstrated that the human heavy chain ferritin (HFt) can encapsu...

  • Article
  • Open Access
18 Citations
5,812 Views
20 Pages

In Vitro Performance of Dutasteride-Nanostructured Lipid Carriers Coated with Lauric Acid-Chitosan Oligomer for Dermal Delivery

  • Norhayati Mohamed Noor,
  • Azila Abdul-Aziz,
  • Khalid Sheikh,
  • Satyanarayana Somavarapu and
  • Kevin M. G. Taylor

Dutasteride, licensed as an oral medicine for the treatment of benign prostatic hypoplasia, has been investigated as a treatment for androgenic alopecia. In this study, the potential for dustasteride to be delivered topically in order to reduce syste...

  • Review
  • Open Access
22 Citations
6,124 Views
19 Pages

Poor water solubility is one of the major challenges to the development of oral dosage forms containing active pharmaceutical ingredients (APIs). Polymorphism in APIs leads to crystals with different surface wettabilities and free energies, which can...

  • Article
  • Open Access
12 Citations
3,612 Views
18 Pages

Targeting EphA2 in Bladder Cancer Using a Novel Antibody-Directed Nanotherapeutic

  • Walid Kamoun,
  • Elden Swindell,
  • Christine Pien,
  • Lia Luus,
  • Jason Cain,
  • Minh Pham,
  • Irawati Kandela,
  • Zhaohua Richard Huang,
  • Suresh K. Tipparaju and
  • Alexander Koshkaryev
  • + 9 authors

Ephrin receptor A2 (EphA2) is a member of the Ephrin/Eph receptor cell-to-cell signaling family of molecules, and it plays a key role in cell proliferation, differentiation, and migration. EphA2 is overexpressed in a broad range of cancers, and its e...

  • Article
  • Open Access
7 Citations
6,446 Views
12 Pages

(1) Background: Inhalant abuse and misuse are still widespread problems. 1,1-Difluoroethane abuse is reported to be potentially fatal and to cause acute and chronic adverse health effects. Lab testing for difluoroethane is seldom done, partly because...

  • Article
  • Open Access
60 Citations
6,520 Views
11 Pages

Controlled Delivery of BET-PROTACs: In Vitro Evaluation of MZ1-Loaded Polymeric Antibody Conjugated Nanoparticles in Breast Cancer

  • Francisco J. Cimas,
  • Enrique Niza,
  • Alberto Juan,
  • María del Mar Noblejas-López,
  • Iván Bravo,
  • Agustín Lara-Sanchez,
  • Carlos Alonso-Moreno and
  • Alberto Ocaña

Bromo and extraterminal domain (BET) inhibitors-PROteolysis TArgeting Chimera (BETi-PROTAC) is a new family of compounds that induce proteasomal degradation through the ubiquitination of the tagged to BET inhibitors Bromodomain proteins, BRD2 and BRD...

of 10

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Pharmaceutics - ISSN 1999-4923Creative Common CC BY license